Joost Peerbooms

135 Discussion 50. Parrish W, Roides B. Physiology of Blood Components in Wound Healing: An Appreciation of Cellular Co-Operativity in Platelet Rich Plasma Action. J Exerc Sports Orthop. 2017; 4: 1–14. 51. Rashid H, Kwoh C. Should Platelet-Rich Plasma or Stem Cell Therapy Be Used to Treat Osteoarthritis? Rheum Dis Clin N Am. 2019; 45: 417–38. 52. Qian Y, Han Q, Chen W, et al. Platelet-Rich Plasma Derived Growth Factors Contribute to Stem Cell Differentiation in Musculoskeletal Regeneration. Front Chem. 2017; 5: 89. 53. Dhillon R, Schwarz E, Maloney M. Platelet-rich plasma therapy-future or trend? Arthritis Res Ther. 2012; 14: 219. 54. Anitua E, Nurden P, Prado R, et al. Autologous fibrin scaffolds: When platelet- and plasma- derived biomolecules meet fibrin. Biomaterials. 2019; 192: 440–60. 55. Mariani E, Filardo G, Canella V, et al. Platelet-rich plasma affects bacterial growth in vitro. Cytotherapy. 2014; 16: 1294–1304. 56. Amable P, Carias R, Teixeira M, et al. Platelet-rich plasma preparation for regenerative medicine: Optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013; 4: 67. 57. Dohan Ehrenfest D, Andia I, Zumstein M, et al. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: Current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014; 4: 3–9. 58. Giusti I, Rughetti A, D’Ascenzo S, et al. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion. 2009; 49: 771–78. 59. Rossi L, Murray I, Chu C, et al. Classification systems for platelet-rich plasma. Bone Jt J. 2019; 101: 891–96. 60. Harrison S, Vavken P, Kevy S, et al. Platelet Activation by Collagen Provides Sustained Release of Anabolic Cytokines. Am J Sports Med. 2011; 39(4): 729–34. 61. Chen X, Jones I, Park C, et al. The Efficacy of Platelet-Rich Plasma on Tendon and Ligament Healing. A Systematic Review and Meta-analysis With Bias Assessment. Am J Sports Med. 2018; 46(8): 2020-32. 62. Everts P, Malanga G, Rowan V. et al. Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies. A review. Regen Ther. 2019; 11: 56–64. 63. Dohan Ehrenfest D, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L- PRF). Trends Biotechnol. 2009; 27: 158-67. 64. Gonnade N, Bajpayee A, Elhence A, et al. Regenerative efficacy of therapeutic quality platelet-rich plasma injections versus phonophoresis with kinesiotaping for the treatment of chronic plantar fasciitis: a prospective randomized pilot study. Asian J Transfus Sci. 2018; 12(2): 105-11. 65. Kane D, Greaney T, Shanahan M, et al. The role of ultrasound sonography in the diagnosis and management of idiopathic plantar fasciitis. Rheumatology (Oxford). 2001; 40: 1002-8. 8